HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, has finalized the acquisition of Dura Medical in Florida.
Dura Medical offers precision psychiatry services, including Ketamine Therapy and Transcranial Magnetic Stimulation, for severe depression and PTSD.
The acquisition is part of HOPE's expansion plan to provide comprehensive psychiatric care along the West Coast of Florida and beyond.
Strategic Acquisition
Dura Medical, along with pending acquisitions, will enhance HOPE's service offerings in interventional psychiatry clinics across multiple locations in Florida.
Experienced Leadership
Stephen Durand, a US Army Veteran and founder of Dura Medical, appointed as Director of Clinic Operations, bringing expertise in precision psychiatry services.
Focus on Veterans' Care
Dura Medical's participation in the VA Community Cares Network ensures access to interventional psychiatry programs for military veterans.
- Dura Medical's focus on suicide prevention aligns with HOPE's mission to provide comprehensive care for depression, PTSD, and anxiety disorders.
- The acquisition strengthens HOPE's network and underscores its commitment to expanding quality psychiatric services in Florida and beyond.
The acquisition of Dura Medical marks a significant step for HOPE Therapeutics in expanding its psychiatric care network and enhancing services for patients in need. The collaboration reinforces the commitment to precision psychiatry and provides hope for improving mental health outcomes.